Overview

Selective Spinal Anaesthesia With Hyperbaric Prilocain With 2%Provides Better Perioperative Hemodynamic Stability for Patients With Peripheral Vascular Disease and Cardiac Dysfunction in Lower Limb Surgery

Status:
Recruiting

Trial end date:
2024-12-01

Target enrollment:

Participant gender:

Summary

to compare the safety and efficacy of spinal anesthesia using Hyperbaric Prilocaine 2% versus Hyperbaric Bupivacaine 0.5% for patients with peripheral vascular disease and cardiac dysfunction.

Phase:

N/A

Details

Lead Sponsor:

Assiut University

Treatments:

Bupivacaine
Prilocaine